TearCare System to Treat Dry Eye Disease (OLYMPIA)
Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the TearCare® System in the Treatment of the Signs and Symptoms of Dry Eye Disease
Sponsor: Sight Sciences, Inc.
This NA trial investigates Dry Eye and Meibomian Gland Dysfunction and is currently completed. Sight Sciences, Inc. leads this study, which shows 11 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Nov 2025 — Present [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2024 — Nov 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Oct 2021 — Dec 2023 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 6 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Recruiting NA
-
Oct 2019 — Feb 2020 [monthly]
Recruiting NA
-
Jun 2019 — Oct 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2019 — Jun 2019 [monthly]
Not Yet Recruiting NA
-
Mar 2019 — Apr 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Sight Sciences, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .